Genesys Capital
Seed → Series C+
Their stated focus (public profile)
Genesys Capital is a Canadian life science venture capital firm focused exclusively on early-stage healthcare and biotech companies. The firm leverages deep relationships with leading North American research institutes and universities to access early-stage discoveries and high-potential deal flow. Genesys takes a 'create and build' approach, partnering closely with scientific founders to build pioneering companies, typically as founding/lead investors. With over 25 years of experience and five funds, they aim to deliver class-leading returns while advancing medicine for patients.
Stages: Seed → Series C+
Sectors: Healthtech, Life sciences
On file: 7 partners on record · 6 companies on record
Website: genesyscapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.